Literature DB >> 25378809

Catalytic Enantioselective Allylic Amination of Olefins for the Synthesis of ent-Sitagliptin.

Hongli Bao1, Liela Bayeh1, Uttam K Tambar1.   

Abstract

The presence of nitrogen atoms in most chiral pharmaceutical drugs has motivated the development of numerous strategies for the synthesis of enantioenriched n class="Chemical">amines. Current methods are based on the multi-step transformation of pre-functionalized allylic electrophiles into chiral allylic amines. The enantioselective allylic amination of unactivated olefins represents a more direct and attractive strategy. We report the enantioselective synthesis of ent-sitagliptin via an allylic amination of an unactivated terminal olefin.

Entities:  

Keywords:  amination; asymmetric catalysis; drugs; palladium; rearrangement

Year:  2013        PMID: 25378809      PMCID: PMC4219538          DOI: 10.1055/s-0033-1340079

Source DB:  PubMed          Journal:  Synlett        ISSN: 0936-5214            Impact factor:   2.454


  20 in total

1.  Allylic Amination.

Authors:  Mogens Johannsen; Karl Anker Jørgensen
Journal:  Chem Rev       Date:  1998-06-18       Impact factor: 60.622

Review 2.  Catalytic C-H amination: recent progress and future directions.

Authors:  Florence Collet; Robert H Dodd; Philippe Dauban
Journal:  Chem Commun (Camb)       Date:  2009-07-07       Impact factor: 6.222

3.  Recent advances in catalytic intramolecular C-H aminations.

Authors:  Huw M L Davies; Matthew S Long
Journal:  Angew Chem Int Ed Engl       Date:  2005-06-06       Impact factor: 15.336

Review 4.  Making carbon-nitrogen bonds in biological and chemical synthesis.

Authors:  Ryan Hili; Andrei K Yudin
Journal:  Nat Chem Biol       Date:  2006-06       Impact factor: 15.040

5.  Mechanistically driven development of iridium catalysts for asymmetric allylic substitution.

Authors:  John F Hartwig; Levi M Stanley
Journal:  Acc Chem Res       Date:  2010-09-28       Impact factor: 22.384

6.  Catalytic C-H amination: the stereoselectivity issue.

Authors:  Florence Collet; Camille Lescot; Philippe Dauban
Journal:  Chem Soc Rev       Date:  2011-01-13       Impact factor: 54.564

Review 7.  Discovery of JANUVIA (Sitagliptin), a selective dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.

Authors:  Nancy A Thornberry; Ann E Weber
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

8.  Catalytic enantioselective allylic amination of unactivated terminal olefins via an ene reaction/[2,3]-rearrangement.

Authors:  Hongli Bao; Uttam K Tambar
Journal:  J Am Chem Soc       Date:  2012-10-29       Impact factor: 15.419

Review 9.  C-C, C-O, C-N bond formation on sp2 carbon by Pd(II)-catalyzed reactions involving oxidant agents.

Authors:  Egle M Beccalli; Gianluigi Broggini; Michela Martinelli; Silvia Sottocornola
Journal:  Chem Rev       Date:  2007-11-01       Impact factor: 60.622

10.  Highly efficient asymmetric synthesis of sitagliptin.

Authors:  Karl B Hansen; Yi Hsiao; Feng Xu; Nelo Rivera; Andrew Clausen; Michele Kubryk; Shane Krska; Thorsten Rosner; Bryon Simmons; Jaume Balsells; Nori Ikemoto; Yongkui Sun; Felix Spindler; Christophe Malan; Edward J J Grabowski; Joseph D Armstrong
Journal:  J Am Chem Soc       Date:  2009-07-01       Impact factor: 15.419

View more
  1 in total

1.  Cycloadditions of Donor-Acceptor Cyclopropanes and -butanes using S=N-Containing Reagents: Access to Cyclic Sulfinamides, Sulfonamides, and Sulfinamidines.

Authors:  Gwyndaf A Oliver; Maximilian N Loch; André U Augustin; Pit Steinbach; Mohammed Sharique; Uttam K Tambar; Peter G Jones; Christoph Bannwarth; Daniel B Werz
Journal:  Angew Chem Int Ed Engl       Date:  2021-10-29       Impact factor: 16.823

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.